Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
1.
Nature ; 613(7943): 303-307, 2023 01.
Artículo en Inglés | MEDLINE | ID: mdl-36631648

RESUMEN

Transport of heat from the interior of the Earth drives convection in the mantle, which involves the deformation of solid rocks over billions of years. The lower mantle of the Earth is mostly composed of iron-bearing bridgmanite MgSiO3 and approximately 25% volume periclase MgO (also with some iron). It is commonly accepted that ferropericlase is weaker than bridgmanite1. Considerable progress has been made in recent years to study assemblages representative of the lower mantle under the relevant pressure and temperature conditions2,3. However, the natural strain rates are 8 to 10 orders of magnitude lower than in the laboratory, and are still inaccessible to us. Once the deformation mechanisms of rocks and their constituent minerals have been identified, it is possible to overcome this limitation thanks to multiscale numerical modelling, and to determine rheological properties for inaccessible strain rates. In this work we use 2.5-dimensional dislocation dynamics to model the low-stress creep of MgO periclase at lower mantle pressures and temperatures. We show that periclase deforms very slowly under these conditions, in particular, much more slowly than bridgmanite deforming by pure climb creep. This is due to slow diffusion of oxygen in periclase under pressure. In the assemblage, this secondary phase hardly participates in the deformation, so that the rheology of the lower mantle is very well described by that of bridgmanite. Our results show that drastic changes in deformation mechanisms can occur as a function of the strain rate.

2.
J Synchrotron Radiat ; 31(Pt 1): 17-27, 2024 Jan 01.
Artículo en Inglés | MEDLINE | ID: mdl-37947304

RESUMEN

In the energy production and transportation industries, numerous metallic structures may be subjected to at least several billions of cycles, i.e. loaded in the very high cycle fatigue domain (VHCF). Therefore, to design structures in the VHCF domain, a reliable methodology is necessary. One useful quantity to characterize plastic activity at the microscopic scale and fatigue damage evolution is the mechanical work supplied to a material. However, the estimation of this mechanical work in a metal during ultrasonic fatigue tests remains challenging. This paper aims to present an innovative methodology to quantify this. An experimental procedure was developed to estimate the mechanical work from stress and total strain evolution measurements during one loading cycle with a time accuracy of about 50 ns. This was achieved by conducting time-resolved X-ray diffraction coupled to strain gauge measurements at a synchrotron facility working in pulsed mode (single-bunch mode).

3.
Opt Express ; 30(7): 10528-10546, 2022 Mar 28.
Artículo en Inglés | MEDLINE | ID: mdl-35473017

RESUMEN

The laser shock peening process (LSP), used to reinforce metals, currently has two major configurations with limitations. (1) Laser irradiation with large spot sizes, but with the need to use a thermal protective coating to avoid detrimental thermal damage (which increases the overall cost of the process) or (2) laser irradiation without thermal coating but with very small spot sizes and high overlap ratios, thus increasing the amount of time required to treat a given surface. In this study, we develop a new faster configuration for the LSP process, which can be applied without a thermal coating, but is still effective regarding surface treatment time. A new laser system has been developed for this faster configuration and has been used to perform the LSP treatment of aluminum alloys at a high-repetition rate. This new DPSS Q-switched Nd:YAG laser, delivers 1 J of energy with a pulse duration from 7 to 21 ns at a very high frequency of 200 Hz. We also studied the laser/matter interaction, according to the laser pulse duration, energy, and its wavelength. The water confinement (ejection and renewing) was monitored while an air-blowing system was implemented to manage water issues identified with this new configuration. Altogether, we demonstrated that such a configuration is fully operational.

4.
Thorac Cardiovasc Surg ; 66(2): 129-134, 2018 03.
Artículo en Inglés | MEDLINE | ID: mdl-28992652

RESUMEN

BACKGROUND: The aim of this study was to explore the feasibility of surgery after two induction cycles of cisplatin-docetaxel followed by concomitant 40 Gy chemoradiation in the treatment of initially unresectable stage III non-small cell lung cancer (NSCLC; TAXCIS protocol), and to evaluate overall survival (OS) and recurrence-free survival (RFS) and recurrence risk factors over a larger cohort of patients with a subgroup analysis of patients treated by pneumonectomy. METHODS: Between 2004 and 2014, a total of 37 patients were treated. Only patients responding to induction treatment were included. RESULTS: We operated on 32 stage IIIA and 5 stage IIIB patients. We performed 12 pneumonectomies, 1 bilobectomy, and 23 lobectomies. Status ypT0N0 was obtained for 35% of the patients. Surgery was considered R0 in 86% of the cases. Postoperative morbidity was 21.6% with a mortality of 10.8% (25% after pneumonectomy). OS was 50% at 5 years. The median RFS was 50 months. RFS was 47% at 5 years. Local or locoregional recurrence was diagnosed in 10.8% of the patients, and distant metastasis in 35.1%. Recurrence risk factors were pneumonectomy (p = 0.001) and a histologically incomplete response (p = 0.04). CONCLUSION: The TAXCIS protocol followed by surgery is feasible for initially unresectable NSCLC stage IIIA and B patients. Benefit was noted in responding lesions with better OS and PFS, except after pneumonectomy.


Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Carcinoma de Pulmón de Células no Pequeñas/terapia , Quimioradioterapia Adyuvante , Neoplasias Pulmonares/terapia , Terapia Neoadyuvante , Neumonectomía , Adulto , Anciano , Protocolos de Quimioterapia Combinada Antineoplásica/efectos adversos , Carcinoma de Pulmón de Células no Pequeñas/mortalidad , Carcinoma de Pulmón de Células no Pequeñas/secundario , Quimioradioterapia Adyuvante/efectos adversos , Quimioradioterapia Adyuvante/mortalidad , Cisplatino/administración & dosificación , Progresión de la Enfermedad , Supervivencia sin Enfermedad , Docetaxel , Estudios de Factibilidad , Femenino , Humanos , Estimación de Kaplan-Meier , Neoplasias Pulmonares/mortalidad , Neoplasias Pulmonares/patología , Masculino , Persona de Mediana Edad , Terapia Neoadyuvante/efectos adversos , Terapia Neoadyuvante/mortalidad , Recurrencia Local de Neoplasia , Estadificación de Neoplasias , Neumonectomía/efectos adversos , Neumonectomía/mortalidad , Modelos de Riesgos Proporcionales , Dosificación Radioterapéutica , Estudios Retrospectivos , Factores de Riesgo , Taxoides/administración & dosificación , Factores de Tiempo , Resultado del Tratamiento
5.
J Appl Crystallogr ; 57(Pt 2): 470-480, 2024 Apr 01.
Artículo en Inglés | MEDLINE | ID: mdl-38596726

RESUMEN

X-ray Laue microdiffraction aims to characterize microstructural and mechanical fields in polycrystalline specimens at the sub-micrometre scale with a strain resolution of ∼10-4. Here, a new and unique Laue microdiffraction setup and alignment procedure is presented, allowing measurements at temperatures as high as 1500 K, with the objective to extend the technique for the study of crystalline phase transitions and associated strain-field evolution that occur at high temperatures. A method is provided to measure the real temperature encountered by the specimen, which can be critical for precise phase-transition studies, as well as a strategy to calibrate the setup geometry to account for the sample and furnace dilation using a standard α-alumina single crystal. A first application to phase transitions in a polycrystalline specimen of pure zirconia is provided as an illustrative example.

6.
J Appl Crystallogr ; 55(Pt 4): 737-750, 2022 Aug 01.
Artículo en Inglés | MEDLINE | ID: mdl-35974740

RESUMEN

A feed-forward neural-network-based model is presented to index, in real time, the diffraction spots recorded during synchrotron X-ray Laue microdiffraction experiments. Data dimensionality reduction is applied to extract physical 1D features from the 2D X-ray diffraction Laue images, thereby making it possible to train a neural network on the fly for any crystal system. The capabilities of the LaueNN model are illustrated through three examples: a two-phase nano-structure, a textured high-symmetry specimen deformed in situ and a polycrystalline low-symmetry material. This work provides a novel way to efficiently index Laue spots in simple and complex recorded images in <1 s, thereby opening up avenues for the realization of real-time analysis of synchrotron Laue diffraction data.

7.
J Appl Crystallogr ; 53(Pt 3): 650-661, 2020 Jun 01.
Artículo en Inglés | MEDLINE | ID: mdl-32684880

RESUMEN

A furnace that covers the temperature range from room temperature up to 2000 K has been designed, built and implemented on the D2AM beamline at the ESRF. The QMAX furnace is devoted to the full exploration of the reciprocal hemispace located above the sample surface. It is well suited for symmetric and asymmetric 3D reciprocal space mapping. Owing to the hemispherical design of the furnace, 3D grazing-incidence small- and wide-angle scattering and diffraction measurements are possible. Inert and reactive experiments can be performed at atmospheric pressure under controlled gas flux. It is demonstrated that the QMAX furnace allows monitoring of structural phase transitions as well as microstructural evolution at the nanoscale, such as self-organization processes, crystal growth and strain relaxation. A time-resolved in situ oxidation experiment illustrates the capability to probe the high-temperature reactivity of materials.

8.
Clin Lung Cancer ; 21(1): 56-65.e8, 2020 01.
Artículo en Inglés | MEDLINE | ID: mdl-31519454

RESUMEN

BACKGROUND: The introduction of liquid biopsy using PCR-based assays into routine practice has had a strong impact on the treatment of EGFR-mutated lung adenocarcinoma and is now commonly used for routine testing of EGFR mutations in certain clinical settings. To assess whether the claimed benefits of PCR-based assays hold true in daily practice at a multicenter clinical institution, we assessed how treatment decisions are affected by PCR-based assays for the analysis of EGFR mutations from plasma samples in a centralized laboratory (LPCE, Nice, France). PATIENTS AND METHODS: A total of 345 samples were analyzed using the US Food and Drug Administration-approved Cobas EGFR Mutation Test v2 and 103 using the Therascreen EGFR Plasma RGQ PCR Kit over 3 years (395 samples from 324 patients). Eleven plasma samples were validated independently using Cobas at 3 institutions, and 130 samples were analyzed using Stilla digital PCR. Clinical data were collected for 175 (54%) of 324 patients. RESULTS: Cobas was superior to the Therascreen assay and demonstrated 100% reproducibility. Digital PCR showed only 48%, 83%, and 58% concordance with Cobas for exon 19 deletions, L858R mutations, and T790M mutations, respectively. Liquid biopsies helped inform and change treatment when resistance occurred and enabled the detection of EGFR mutations in patients when biopsy tissue results were unavailable. CONCLUSION: PCR-based assays are a fast and convenient test, allowing the detection of primary and secondary EGFR mutations from plasma. Cobas proved to be a reliable test, whereas digital PCR produced too many inconclusive results to be currently recommended as a principal testing device.


Asunto(s)
Carcinoma de Pulmón de Células no Pequeñas/diagnóstico , Técnicas de Laboratorio Clínico/normas , Análisis Mutacional de ADN/métodos , Neoplasias Pulmonares/diagnóstico , Mutación , Adulto , Anciano , Anciano de 80 o más Años , Carcinoma de Pulmón de Células no Pequeñas/sangre , Carcinoma de Pulmón de Células no Pequeñas/genética , Receptores ErbB/genética , Femenino , Francia , Humanos , Biopsia Líquida , Neoplasias Pulmonares/sangre , Neoplasias Pulmonares/genética , Masculino , Persona de Mediana Edad , Reproducibilidad de los Resultados
9.
Expert Rev Anticancer Ther ; 17(8): 681-685, 2017 08.
Artículo en Inglés | MEDLINE | ID: mdl-28511612

RESUMEN

INTRODUCTION: The advent of genomic based precision medicine led to the implementation of biomarker testing in metastatic non-small cell lung cancer (NSCLC) patients. Next generation sequencing (NGS) has been recently implemented to routine diagnostic requirements in lung oncology. Areas covered: Two cases of patients with metastatic NSCLC for whom NGS analysis performed on both tumor and liquid biopsy has not improved the clinical course of their disease are reported. These cases illustrate the difficulty of the so-called 'personalized or precision' medicine in clinical routine practice for metastatic NSCLC. Expert commentary: Discovery and detection of critical cancer-gene alterations better indicates targeted therapies that must be administered to improve the care of NSCLC patients in the personalized medicine era. There has been much interest in the literature and the scientific community for NGS tailored therapies approach for patients. However, there may be a gap between this theoretical stratified medicine and clinical practice. The advantages and drawbacks of NGS on tumor tissue and cell-free DNA for metastatic NSCLC are discussed.


Asunto(s)
Carcinoma de Pulmón de Células no Pequeñas/genética , Secuenciación de Nucleótidos de Alto Rendimiento/métodos , Neoplasias Pulmonares/genética , Terapia Molecular Dirigida , Adulto , Carcinoma de Pulmón de Células no Pequeñas/tratamiento farmacológico , Carcinoma de Pulmón de Células no Pequeñas/patología , ADN de Neoplasias , Genotipo , Humanos , Neoplasias Pulmonares/tratamiento farmacológico , Neoplasias Pulmonares/patología , Masculino , Persona de Mediana Edad , Metástasis de la Neoplasia , Medicina de Precisión/métodos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA